Used in pharmaceutical research as an intermediate for synthesizing bioactive compounds, particularly in the development of kinase inhibitors. Shows potential in studies related to central nervous system disorders due to its ability to cross the blood-brain barrier. Also employed in radiolabeling studies for positron emission tomography (PET) imaging because of the presence of iodine, enabling tracking of biological pathways in vivo. Its fluorobenzyl group enhances metabolic stability, making it suitable for drug design targeting neurological and inflammatory conditions.